Skip to main content

and
  1. Article

    Abstract

    Ch. Mache, Ch. Urban, H. Sauer, G. Brandesky, H. Meßner in Annals of Hematology (1992)

  2. No Access

    Article

    Translocation of c-abl oncogene and PDGFB (c-sis) gene in a case of CML with 46, XY, t(22;22)

    In a case of CML with a variant Philadelphia translocation (Ph1 or Ph) t (22;22) (q11;q13) in bone marrow cells and unstimulated peripheral blood cells, no cytogenetically detectable involvement of chromosome 9 w...

    G. Gradl, H. Tesch, G. Schwieder, T. Wagner, C. Fonatsch in Blut (1989)

  3. No Access

    Article

    Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin

    Fosfomycin and mesna were investigated in rats and mice concerning their detoxifying effects on cisplatin toxicity in comparison to sodium thiosulfate, a known protector against cisplatin nephrotoxicity. After...

    T. Wagner, B. Kreft, G. Bohlmann in Journal of Cancer Research and Clinical On… (1988)

  4. No Access

    Article

    Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide

    Presumably the coadministration of the uroprotector mesna in cyclophosphamide treatment does not influence the systemic activity of its activated metabolite. This was newly investigated in a mouse model. The LD50

    T. Wagner, M. Zink, G. Schwieder in Journal of Cancer Research and Clinical Oncology (1987)